Press "Enter" to skip to content

Alembic Pharma gets USFDA nod for ophthalmic solution

The approved product is therapeutically equivalent to the reference listed drug (RLD), Bromday Ophthalmic Solution, 0.09 per cent, of Bausch & Lomb.

Original source: https://health.economictimes.indiatimes.com/news/pharma/alembic-pharma-gets-usfda-nod-for-ophthalmic-solution/69923973?utm_source=RSS&utm_medium=ETRSS

Also Read:   Taiho Pharmaceuticals moves US court against Natco on generic cancer drug